Stenabolic (SR-9009) – 10MG 50CT

SR9009, also known as Stenabolic, is a SARM that was developed at the Scripps Research Institute. It is a PPAR alpha modifier very similar GW­-501516. It binds to the Rev-erbα protein, which influences lipid and glucose metabolism in the liver and the creation of fat-storing cells.